405 related articles for article (PubMed ID: 1821372)
41. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
42. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
Gold LS; Slone TH
J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
[TBL] [Abstract][Full Text] [Related]
43. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
[TBL] [Abstract][Full Text] [Related]
44. Short-term tests in the framework of carcinogen risk assessment to man.
Kroes R
Ann N Y Acad Sci; 1983; 407():398-408. PubMed ID: 6576683
[TBL] [Abstract][Full Text] [Related]
45. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
46. Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop.
Kirkland D; Zeiger E; Madia F; Gooderham N; Kasper P; Lynch A; Morita T; Ouedraogo G; Parra Morte JM; Pfuhler S; Rogiers V; Schulz M; Thybaud V; van Benthem J; Vanparys P; Worth A; Corvi R
Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():55-68. PubMed ID: 25435356
[TBL] [Abstract][Full Text] [Related]
47. Quantitative correlation of carcinogenic potency with four different classes of short-term test data.
Travis CC; Wang LA; Waehner MJ
Mutagenesis; 1991 Sep; 6(5):353-60. PubMed ID: 1795638
[TBL] [Abstract][Full Text] [Related]
48. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
[TBL] [Abstract][Full Text] [Related]
49. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.
Elcombe CR; Odum J; Foster JR; Stone S; Hasmall S; Soames AR; Kimber I; Ashby J
Environ Health Perspect; 2002 Apr; 110(4):363-75. PubMed ID: 11940454
[TBL] [Abstract][Full Text] [Related]
50. The JaCVAM international validation study on the in vivo comet assay: Selection of test chemicals.
Morita T; Uno Y; Honma M; Kojima H; Hayashi M; Tice RR; Corvi R; Schechtman L
Mutat Res Genet Toxicol Environ Mutagen; 2015 Jul; 786-788():14-44. PubMed ID: 26212294
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
Bartsch H; Malaveille C
Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
[TBL] [Abstract][Full Text] [Related]
52. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances.
Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P
ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445
[TBL] [Abstract][Full Text] [Related]
53. Prediction of carcinogenic potency by short-term genotoxicity tests.
Ennever FK; Rosenkranz HS
Mutagenesis; 1987 Jan; 2(1):39-44. PubMed ID: 3331693
[TBL] [Abstract][Full Text] [Related]
54. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis.
Benigni R; Bossa C; Tcheremenskaia O
Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285
[TBL] [Abstract][Full Text] [Related]
55. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
[TBL] [Abstract][Full Text] [Related]
56. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
57. Carcinogenicity evaluations and ongoing studies: the IARC databases.
Vainio H; Coleman M; Wilbourn J
Environ Health Perspect; 1991 Dec; 96():5-9. PubMed ID: 1820277
[TBL] [Abstract][Full Text] [Related]
58. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
59. Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern.
Kirkland D; Fowler P
Mutagenesis; 2010 Nov; 25(6):539-53. PubMed ID: 20720197
[TBL] [Abstract][Full Text] [Related]
60. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
Bartsch H; Malaveille C
IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
